Vitamin D Supplementation Prevents Elderly Pneumonia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00877422|
Recruitment Status : Completed
First Posted : April 7, 2009
Last Update Posted : April 8, 2009
|Condition or disease||Intervention/treatment||Phase|
|Bacterial Pneumonia||Dietary Supplement: Vitamin D3||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||100 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Vitamin D Supplementation Prevents Pneumonia in Institutionalized Elderly Subjects|
|Study Start Date :||August 2008|
No Intervention: Group A
Group A is identified as serum vitamin D level more than 16 ng/dl.
Active Comparator: Group B
Group B is identified as serum vitamin D level less than 16 ng/dl and is supplemented with vitamin D3.
Dietary Supplement: Vitamin D3
Group A and Group C are followed without drugs and Group B is followed with vitamin D3.
No Intervention: Group C
Group C is identified as serum vitamin D less than 16 ng/dl and is not supplemented with vitamin D3.
- prevalence of pneumonia [ Time Frame: one year ]
- all cause mortality [ Time Frame: one year ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00877422
|Institute of Development, Aging and Cancer, Tohoku University|
|1-1,Seiryo-machi,Aoba-ku,Sendai, Japan, 980-8575|
|Study Chair:||Hiroyuki Arai, MD||Department of Geriatrics and Gerontology, Tohoku University|